Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04311437
Other study ID # CMRPG8K0461
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 1, 2020
Est. completion date February 28, 2023

Study information

Verified date July 2021
Source Chang Gung Memorial Hospital
Contact Chun-Ting Liu, MD
Phone +886-7-7317123
Email juntin0214@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Middle ear barotrauma (MEB) is the most common complication during hyperbaric oxygen therapy (HBOT). Though Valsalva and Toynbee maneuvers have been proposed to prevent MEB, still some patients discontinue HBOT due to severe otalgia, hemorrhage or perforation of tympanic membrane associated with HBOT. Currently, there is no optimal prophylactic management for MEB associated with HBOT. The aim of this protocol is to investigate the efficacy of self-acupressure therapy on MEB associated with HBOT.


Recruitment information / eligibility

Status Recruiting
Enrollment 152
Est. completion date February 28, 2023
Est. primary completion date February 28, 2023
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: - Aged 20 years or order receiving the first HBOT - Alert consciousness Exclusion Criteria: - Pregnancy - Having any acute disorder of the ears or upper respiratory tract - Having evidence of neurologic dysfunction precluding them from making an informed decision - Having a tracheostomy or endotracheal intubation - Having received a myringotomy, tympanoplasty, mastoidectomy or tympanostomy tube placement.

Study Design


Intervention

Procedure:
Self-acupressure therapy
The self-acupressure therapy is as follows: Patients are in sitting position, applied firm pressure (3-5 kg of pressure) with the fingertips in a circular motion at a speed of two circles per second for a duration of one min per acupoint. A 1-2-s rest is applied after each ten circles. The complete process lasts for about 5 min.
Combined Valsalva and Toynbee maneuvers
Valsalva maneuver: blowing against a closed mouth and nostrils, increasing the middle ear pressure. Toynbee maneuver: swallowing while the mouth and nostrils are closed, decreasing the middle ear pressure.

Locations

Country Name City State
Taiwan Kaohsiung Chang Gung Memorial Hospital Kaohsiung

Sponsors (1)

Lead Sponsor Collaborator
Chang Gung Memorial Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Modified Teed Classification The Modified Teed Classification, with grades from 0 to 5: Grade 0 indicates symptoms with no ontological signs of trauma; Grade 1 indicates injection of the tympanic membrane; Grade 2 indicates Grade 1 plus injection plus mild hemorrhage within the tympanic membrane; Grade 3 indicates gross hemorrhage within the tympanic membrane; Grade 4 indicates free blood in the middle ear as evidenced by blueness and bulging; and Grade 5 indicates perforation of the tympanic membrane. 1 month
Secondary Symptoms of MEB Record the symptoms of MEB including feeling pressure in the ears, ear pain, headache, dizziness, vertigo, tinnitus and hearing loss. Each symptom is estimated using a 10-cm visual analogue scale with anchor points of 0 (no discomfort) and 10 (maximum discomfort). 1 month
Secondary Overall ear discomfort levels Estimated using a 10-cm visual analogue scale with anchor points of 0 (no discomfort) and 10 (maximum discomfort). 1 month
See also
  Status Clinical Trial Phase
Suspended NCT01365780 - Hyperbaric Oxygen Therapy in Distal Radius Fractures: Can it Shorten Recovery Time and Increase Fracture Healing? N/A
Completed NCT05136716 - Effect of Hyperbaric Oxygen Therapy on Cerebral Palsy N/A
Recruiting NCT05289700 - Hyperbaric-oxygen Therapy (HBOT) Versus Placebo for Treating Vaso-Occlusive Crisis (VOC) in Sickle Cell Disease (SCD) Phase 3
Recruiting NCT05031949 - Hyperbaric Oxygen Therapy Combined Camrelizumab in Patients With Advanced/Metastatic Hepatocellular Carcinoma Phase 1
Recruiting NCT03144206 - Hyperbaric Oxygen Therapy for Soft Tissue Sarcoma Pilot Study Phase 4
Recruiting NCT05078073 - HBOT in the Treatment and Prevention of aGVHD N/A
Completed NCT04358796 - Measuring Cognitive Enhancement During Hyperbaric Oxygen Treatments N/A
Terminated NCT03339037 - Hyperbaric Oxygen Therapy Effect on Post Concussion Syndrome in Children N/A
Enrolling by invitation NCT02452619 - MRI Brain Changes Induced by Hyperbaric Oxygen Therapy in Brain Injury Patients N/A
Not yet recruiting NCT04376359 - The Effectiveness of Hyperbaric Oxygen Therapy on Pneumonia Complicating Stroke N/A
Completed NCT02619383 - HBOT Application in Erectile Dysfunction Phase 1
Completed NCT03980210 - Effect of Hyperbaric Oxygen Therapy on Microcirculation N/A
Not yet recruiting NCT03526796 - Hyperbaric Oxygen Therapy for Antibiotic Refractory Pouchitis N/A
Completed NCT03615755 - Short Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine N/A
Not yet recruiting NCT05980195 - Cognitive Improvement After Carotid Stenting in Hyperbaric Oxygen Therapy Trial N/A